Millennium Pharmaceuticals, Inc. (MLNM) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Icebrg	10/10/2007 3:41:24 AM
	Read Replies (1) of 3044

Piper Jaffray & Co. Resumes Coverage of Millennium Pharmaceuticals (MLNM) at Market Perform 10-09-2007 04:30:48 PM Piper Jaffray & Co. resumes coverage of Millennium Pharmaceuticals (Nasdaq: MLNM) at Market Perform with an $11 price target. The firm said, "Our target is based on a 30x multiple on 2010 non-GAAP EPS of $0.56 discounted back at 25% annually; we believe this discount rate is appropriate due to Velcade competition and the early nature of the pipeline."

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next